-24.30 (-1.91%) Further to the intimation dated June 2, 2018 with regard to the audit of the API Srikakulam Plant (SEZ), Andhra Pradesh, Dr. Reddys Laboratories has informed that the Company has received an Establishment Inspection Report (EIR) from the US FDA, for the above-referred facility, indicating closure of the audit.
The above information is a part of company’s filings submitted to BSE.